Search Results - "ZHENG Fangchao"

Recent Progress of Palbociclib in Treatment of HR+/HER2- Breast Cancer

ZHENG Fangchao, DU Feng, LIU Haolin, WANG Xue, YUE Jian, YUAN Peng

electronic resource

View item; View item

Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews

WANG Xue, YUAN Peng, YUE Jian, SI Yiran, HU Nanlin, ZHENG Fangchao, JIANG Peidi

electronic resource

View item; View item

Potential prognostic value of HER2/CEP17 FISH ratio in HER2-positive non-metastatic breast cancer: a real-world study

Zheng, Fangchao^{Aff1, Aff2}, Du, Feng^Aff3, Yang, Zixuan, Wang, Xue, Yue, Jian, Ling, Yun, Yuan, Peng^{Aff1, IDs12672025024952_cor1}

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study

Huang, Jie, Sun, Shujuan, Tan, Qiaorui, Zheng, Fangchao, Zhou, Dongdong, Man, Xiaochu, Hu, Yu, Li, Wenhuan, Song, Lihua, Zhang, Baoxuan, Xu, Liang, Wang, Xinzhao, Xie, Xuemei, Li, Huihui

Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up

Zheng, Fangchao, Du, Feng, Wang, Wenmiao, Wang, Yongsheng, Li, Ming, Zhao, Jiuda, Wang, Xue, Yue, Jian, Wang, Jiayu, Yang, Zixuan, Cai, Ruigang, Ma, Fei, Fan, Ying, Li, Qing, Zhang, Pin, Xu, Binghe^{Aff1, IDs10549021064016_cor16}, Yuan, Peng^{Aff1, Aff7, IDs10549021064016_cor17}

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer

Zheng, Fangchao^{Aff1, Aff2}, Wei, Tong, Wang, Xue, Du, Feng, Yue, Jian, Yuan, Peng^{Aff1, IDs40164022003088_cor6}

This result is not displayed to guests.
Login for full access.

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Zheng, Fangchao, Du, Feng, Zhao, Jiuda, Wang, Xue, Si, Yiran, Jin, Peng, Qian, Haili, Xu, Binghe, Yuan, Peng^{Aff1, Aff4}

Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

Zheng, Fangchao, Du, Feng, Qian, Haili, Zhao, Jiuda, Wang, Xue, Yue, Jian, Hu, Nanlin, Si, Yiran, Xu, Binghe, Yuan, Peng^{Aff1, Aff5}

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis

Guo, Xinjian, Zhao, Fuxing, Ma, Xinfu, Shen, Guoshuang, Ren, Dengfeng, Zheng, Fangchao^{Aff1, Aff2, Aff3}, Du, Feng, Wang, Ziyi, Ahmad, Raees, Yuan, Xinyue, Zhao, Junhui^Aff1, Zhao, Jiuda^Aff1

This result is not displayed to guests.
Login for full access.

The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors

Zhao, Jiuda, Du, Feng, Luo, Yang, Shen, Guoshuang, Zheng, Fangchao, Xu, Binghe

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Shen, Guoshuang, Zheng, Fangchao^{Aff1, Aff2}, Ren, Dengfeng, Du, Feng, Dong, Qiuxia, Wang, Ziyi, Zhao, Fuxing, Ahmad, Raees, Zhao, Jiuda^Aff1

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.